Nixon Peabody Trust CO Biogen Inc. Transaction History

Nixon Peabody Trust CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 01, 2019	SELL	$219.29 - $241.72 $1.58 Million - $1.74 Million	-7,186 Closed	0 $0
Q1 2019 Apr 19, 2019	BUY	$216.71 - $338.96 $138,044 - $215,917	637 Added 9.73%	7,186 $1.7 Million
Q4 2018 Jan 23, 2019	BUY	$278.5 - $352.75 $11,418 - $14,462	41 Added 0.63%	6,549 $1.97 Million
Q3 2018 Oct 25, 2018	SELL	$293.51 - $383.83 $74,258 - $97,108	-253 Reduced 3.74%	6,508 $2.3 Million
Q2 2018 Jul 30, 2018	BUY	$257.52 - $306.91 $61,804 - $73,658	240 Added 3.68%	6,761 $1.96 Million
Q1 2018 Apr 27, 2018	BUY	$260.13 - $367.91 $40,840 - $57,761	157 Added 2.47%	6,521 $1.79 Million
Q4 2017 Feb 05, 2018	BUY	$307.64 - $344.58 $39,993 - $44,795	130 Added 2.09%	6,364 $2.03 Million
Q3 2017 Nov 01, 2017	BUY	$281.15 - $329.69 $1.75 Million - $2.06 Million	6,234	6,234 $1.95 Million

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Nixon Peabody Trust CO, based on Form 13F filings with the SEC.

Stay updated on Nixon Peabody Trust CO with notifications on news.